Sol Capital Management Co Has Lifted Teva Pharmaceutical Industries (TEVA) Stake; Q2 Holdings (QTWO) Had 10 Analysts Last Week

September 13, 2017 - By Clifton Ray

Among 11 analysts covering Q2 Holdings Inc (NYSE:QTWO), 10 have Buy rating, 0 Sell and 1 Hold. Therefore 91% are positive. Q2 Holdings Inc had 21 analyst reports since August 4, 2015 according to SRatingsIntel. Needham maintained it with “Buy” rating and $42 target in Friday, February 17 report. RBC Capital Markets maintained Q2 Holdings Inc (NYSE:QTWO) rating on Thursday, August 3. RBC Capital Markets has “Buy” rating and $4300 target. Canaccord Genuity maintained it with “Buy” rating and $32.0 target in Friday, August 7 report. The stock has “Outperform” rating by RBC Capital Markets on Friday, August 7. The firm earned “Buy” rating on Friday, August 7 by Needham. The firm earned “Buy” rating on Thursday, August 3 by Stifel Nicolaus. Canaccord Genuity maintained it with “Buy” rating and $4300 target in Monday, June 5 report. The firm earned “Buy” rating on Tuesday, June 21 by Needham. The rating was initiated by Loop Capital with “Buy” on Tuesday, January 10. Pacific Crest initiated Q2 Holdings Inc (NYSE:QTWO) on Friday, November 18 with “Sector Weight” rating. See Q2 Holdings Inc (NYSE:QTWO) latest ratings:

10/09/2017 Broker: RBC Capital Markets Rating: Buy New Target: $43.0 Maintain
03/08/2017 Broker: Stifel Nicolaus Rating: Buy New Target: $45.0000 Maintain
03/08/2017 Broker: RBC Capital Markets Rating: Buy New Target: $43.0000 Maintain
30/07/2017 Broker: Canaccord Genuity Rating: Buy New Target: $43.0000 Maintain
05/06/2017 Broker: Canaccord Genuity Rating: Buy New Target: $43.0000 Maintain
27/06/2017 Broker: Suntrust Robinson Rating: Buy New Target: $45.00 Initiate
27/06/2017 Broker: SunTrust Rating: Buy New Target: $45 Initiates Coverage On

Sol Capital Management Co increased Teva Pharmaceutical Industries (TEVA) stake by 62.64% reported in 2016Q4 SEC filing. Sol Capital Management Co acquired 21,576 shares as Teva Pharmaceutical Industries (TEVA)’s stock declined 15.11%. The Sol Capital Management Co holds 56,023 shares with $2.03 million value, up from 34,447 last quarter. Teva Pharmaceutical Industries now has $19.19B valuation. The stock declined 1.97% or $0.38 reaching $18.95 on the news. About 169,192 shares traded. Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) has declined 41.70% since September 13, 2016 and is downtrending. It has underperformed by 58.40% the S&P500.

Among 29 analysts covering Teva Pharma (NYSE:TEVA), 8 have Buy rating, 4 Sell and 17 Hold. Therefore 28% are positive. Teva Pharma had 89 analyst reports since July 21, 2015 according to SRatingsIntel. RBC Capital Markets maintained it with “Outperform” rating and $58 target in Monday, November 14 report. The stock of Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) earned “Outperform” rating by RBC Capital Markets on Wednesday, November 16. Credit Suisse initiated it with “Neutral” rating and $60 target in Wednesday, May 4 report. Cantor Fitzgerald initiated Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) on Friday, June 16 with “Neutral” rating. Mizuho upgraded Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) rating on Friday, June 16. Mizuho has “Buy” rating and $30 target. Maxim Group maintained the stock with “Buy” rating in Wednesday, January 4 report. The rating was downgraded by Citigroup on Wednesday, August 16 to “Neutral”. Standpoint Research maintained Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) rating on Monday, July 27. Standpoint Research has “Buy” rating and $84 target. JP Morgan reinitiated Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) on Monday, August 3 with “Overweight” rating. The stock has “Buy” rating by BTIG Research on Monday, September 11.

Investors sentiment decreased to 1.61 in Q4 2016. Its down 0.18, from 1.79 in 2016Q3. It worsened, as 15 investors sold Q2 Holdings Inc shares while 38 reduced holdings. 14 funds opened positions while 43 raised stakes. 32.89 million shares or 3.27% more from 31.85 million shares in 2016Q3 were reported. Strs Ohio accumulated 7,600 shares. Teachers Retirement Of The State Of Kentucky holds 18,553 shares or 0.01% of its portfolio. Clearbridge Limited Liability owns 528,196 shares for 0.34% of their portfolio. 763,803 were reported by Loomis Sayles Limited Partnership. Magee Thomson Inv Ltd Company owns 55 shares or 0% of their US portfolio. Schwab Charles Invest Management holds 102,146 shares. Blackrock Institutional Tru Na holds 0% in Q2 Holdings Inc (NYSE:QTWO) or 870,307 shares. Lpl Financial Lc reported 0% of its portfolio in Q2 Holdings Inc (NYSE:QTWO). Rhumbline Advisers invested 0% of its portfolio in Q2 Holdings Inc (NYSE:QTWO). The New York-based Morgan Stanley has invested 0% in Q2 Holdings Inc (NYSE:QTWO). Voya Invest Ltd Liability Corp reported 10,316 shares or 0% of all its holdings. First Mercantile Co owns 2,160 shares for 0.01% of their portfolio. Wellington Mgmt Group Incorporated Limited Liability Partnership stated it has 0% of its portfolio in Q2 Holdings Inc (NYSE:QTWO). Aqr Capital Limited Liability Company holds 0% or 8,398 shares. Tiaa Cref Inv Ltd Company invested 0% in Q2 Holdings Inc (NYSE:QTWO).

Q2 Holdings, Inc. is a provider of cloud digital banking solutions. The company has market cap of $1.69 billion. The Firm enables regional and community financial institutions , to deliver a suite of integrated digital banking services. It currently has negative earnings. The Company’s solutions all operate on a common platform that supports the delivery of unified digital banking services across online, mobile and voice channels.

Since March 15, 2017, it had 0 insider purchases, and 18 sales for $19.34 million activity. Blue Adam D had sold 25,000 shares worth $983,250. Another trade for 125,000 shares valued at $4.38 million was sold by ADAMS STREET PARTNERS LLC. Another trade for 28,885 shares valued at $1.14 million was sold by BROWN MICHAEL MAURICE. Shares for $549,738 were sold by Furrer William M on Wednesday, May 24. Breeden John E sold 7,500 shares worth $298,200. 192,500 shares were sold by Seale R. H., worth $6.80 million on Monday, March 20. Shares for $35,200 were sold by Offerdahl James.